Met Life Investment Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

  • $16.5 Billion
  • Q2 2025

A detailed history of Met Life Investment Management, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 7,761 shares of ALNY stock, worth $3.58 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,761
Previous 7,295 6.39%
Holding current value
$3.58 Million
Previous $1.97 Million 28.49%
% of portfolio
0.02%
Previous 0.01%

Shares

40 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$224.32 - $326.09 $104,533 - $151,957
466 Added 6.39%
7,761 $2.53 Million
Q1 2025

May 14, 2025
SELL
$233.07 - $290.7 $2,097 - $2,616
-9 Reduced 0.12%
7,295 $1.97 Million
Q4 2024

Feb 13, 2025
SELL
$232.27 - $300.43 $3,251 - $4,206
-14 Reduced 0.19%
7,304 $1.72 Million
Q3 2024

Nov 13, 2024
SELL
$233.81 - $287.01 $33,668 - $41,329
-144 Reduced 1.93%
7,318 $2.01 Million
Q2 2024

Aug 13, 2024
BUY
$143.31 - $247.0 $122,673 - $211,432
856 Added 12.96%
7,462 $1.81 Million
Q1 2024

May 14, 2024
BUY
$146.51 - $198.2 $967,845 - $1.31 Million
6,606 New
6,606 $987,000
Q4 2023

Feb 14, 2024
SELL
$151.41 - $196.57 $13,929 - $18,084
-92 Reduced 1.39%
6,504 $1.24 Million
Q3 2023

May 09, 2024
SELL
$170.77 - $211.65 $145,837 - $180,749
-854 Reduced 11.46%
6,596 $1.17 Million
Q3 2023

Apr 29, 2024
BUY
$170.77 - $211.65 $683 - $846
4 Added 0.06%
6,596 $1.17 Million
Q3 2023

Nov 14, 2023
BUY
$170.77 - $211.65 $683 - $846
4 Added 0.06%
6,596 $1.17 Million
Q2 2023

Apr 29, 2024
BUY
$185.01 - $212.05 $1.22 Million - $1.4 Million
6,592 New
6,592 $1.25 Million
Q2 2023

Aug 10, 2023
SELL
$185.01 - $212.05 $158,738 - $181,938
-858 Reduced 11.52%
6,592 $1.25 Million
Q1 2023

May 09, 2024
BUY
$182.66 - $235.53 $1.36 Million - $1.75 Million
7,450 New
7,450 $1.49 Billion
Q1 2023

May 15, 2023
BUY
$182.66 - $235.53 $3,287 - $4,239
18 Added 0.24%
7,450 $1.49 Million
Q4 2022

May 10, 2024
SELL
$185.53 - $241.31 $10,760 - $13,995
-58 Reduced 0.77%
7,432 $1.77 Million
Q4 2022

Jun 14, 2023
SELL
$185.53 - $241.31 $3,339 - $4,343
-18 Reduced 0.24%
7,432 $1.77 Million
Q4 2022

Mar 22, 2023
SELL
$185.53 - $241.31 $10,760 - $13,995
-58 Reduced 0.77%
7,432 $1.77 Million
Q4 2022

Feb 15, 2023
SELL
$185.53 - $241.31 $10,760 - $13,995
-58 Reduced 0.77%
7,432 $1.77 Million
Q3 2022

May 10, 2024
BUY
$138.54 - $232.0 $692 - $1,160
5 Added 0.07%
7,490 $1.5 Million
Q3 2022

Jun 14, 2023
BUY
$138.54 - $232.0 $5,541 - $9,280
40 Added 0.54%
7,490 $1.5 Million
Q3 2022

Mar 22, 2023
BUY
$138.54 - $232.0 $692 - $1,160
5 Added 0.07%
7,490 $1.5 Million
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $692 - $1,160
5 Added 0.07%
7,490 $1.5 Million
Q2 2022

May 10, 2024
SELL
$120.42 - $169.29 $33,476 - $47,062
-278 Reduced 3.58%
7,485 $1.09 Million
Q2 2022

Jun 20, 2023
BUY
$120.42 - $169.29 $4,214 - $5,925
35 Added 0.47%
7,485 $1.09 Million
Q2 2022

Mar 22, 2023
SELL
$120.42 - $169.29 $33,476 - $47,062
-278 Reduced 3.58%
7,485 $1.09 Million
Q2 2022

Aug 11, 2022
SELL
$120.42 - $169.29 $33,476 - $47,062
-278 Reduced 3.58%
7,485 $1.09 Million
Q1 2022

May 10, 2024
BUY
$127.18 - $173.91 $987,298 - $1.35 Million
7,763 New
7,763 $1.27 Million
Q1 2022

Jun 20, 2023
BUY
$127.18 - $173.91 $39,807 - $54,433
313 Added 4.2%
7,763 $1.27 Million
Q1 2022

Mar 22, 2023
BUY
$127.18 - $173.91 $970,892 - $1.33 Million
7,634 Added 5917.83%
7,763 $1.27 Million
Q1 2022

May 12, 2022
BUY
$127.18 - $173.91 $987,298 - $1.35 Million
7,763 New
7,763 $1.27 Million
Q2 2019

Aug 14, 2019
SELL
$65.86 - $92.79 $8,495 - $11,969
-129 Closed
0 $0
Q1 2019

Jul 13, 2023
SELL
$72.76 - $93.45 $532,675 - $684,147
-7,321 Reduced 98.27%
129 $12,000
Q1 2019

Mar 22, 2023
BUY
$72.76 - $93.45 $509 - $654
7 Added 5.74%
129 $12,000
Q1 2019

May 15, 2019
BUY
$72.76 - $93.45 $509 - $654
7 Added 5.74%
129 $12,000
Q4 2018

Jul 13, 2023
SELL
$62.67 - $88.33 $459,245 - $647,282
-7,328 Reduced 98.36%
122 $8,000
Q4 2018

Mar 22, 2023
SELL
$62.67 - $88.33 $62 - $88
-1 Reduced 0.81%
122 $8,000
Q4 2018

Feb 14, 2019
SELL
$62.67 - $88.33 $62 - $88
-1 Reduced 0.81%
122 $9,000
Q3 2018

Jul 13, 2023
SELL
$87.52 - $122.67 $641,259 - $898,803
-7,327 Reduced 98.35%
123 $10,000
Q3 2018

Mar 22, 2023
SELL
$87.52 - $122.67 $639,683 - $896,595
-7,309 Reduced 98.34%
123 $10,000
Q3 2018

Nov 14, 2018
BUY
$87.52 - $122.67 $10,764 - $15,088
123 New
123 $11,000

Others Institutions Holding ALNY

# of Institutions
742
Shares Held
115M
Call Options Held
584K
Put Options Held
672K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $56.7B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email